# Shaoli Song

Source: https://onco.cc/people/song-shaoli/  
OnCo record `song-shaoli` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Leads the nuclear medicine group behind the first human TROP2 PET imaging, aiming to pick patients for TROP2 ADCs with a scan.

## Summary

Shaoli Song is Professor and Director of the Department of Nuclear Medicine at Fudan University Shanghai Cancer Center. Her department developed and imaged the first TROP2-targeted PET tracers in patients with breast and other cancers, with the aim of selecting patients for TROP2 antibody-drug conjugates using a scan, alongside FAPI, HER2 and PSMA theranostic work. Her publications include head-to-head comparisons of FDG and FAPI PET-CT in recurrent soft tissue sarcoma and in platinum-sensitive recurrent ovarian cancer, and a study of preoperative FDG PET parameters for predicting microvascular invasion and recurrence in hepatocellular carcinoma. Her interests are PET tracer development and theranostics.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor and Director, Department of Nuclear Medicine, Fudan University Shanghai Cancer Center
- Specialisms: Nuclear medicine; PET tracer development; TROP2 and HER2 PET; Theranostics

## Sources

- Fudan University Shanghai Cancer Center: https://www.shca.org.cn
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Song%20S%5BAuthor%5D%20Fudan%20TROP2%20PET

## Connected records

- cancers: [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- technologies: [FAPI PET](https://onco.cc/technologies/fapi-pet/), [HER2 PET](https://onco.cc/technologies/her2-pet/), [TROP2 PET](https://onco.cc/technologies/trop2-pet/)
- targets: [FAP](https://onco.cc/targets/fap/), [TROP2](https://onco.cc/targets/trop2/)
- institutions: [Fudan University Shanghai Cancer Center](https://onco.cc/institutions/fuscc/)

---
JSON: https://onco.cc/api/v1/entities/song-shaoli.json